Barrett-Connor E. and Bush TL (1991). Estrogen and coronary heart disease in women. JAMA265: 1861-1867.
2.
Curtis S., Washburn T., Sewall C., DiAugustine R., Lindzey J., Couse JF, and Korach KS (1996). Physiological coupling of growth factor and steroid receptor signaling pathways: Estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc. Natl. Acad. Sci. U.S.A. 93: 12626-12630.
3.
Ettinger B., Genant HK, and Cann CE (1985). Long-term estrogen replacement therapy prevents bone loss and fractures. Ann. Intern. Med. 102: 319-324.
4.
Korach KS (1994). Insights from the study of animals lacking functional estrogen receptor. Science266: 1524-1527.
5.
Korach KS, Couse JF, Curtis SW, Washburn TF, Lindzey J., Kimbro KS, Eddy EM, Migliaccio S., Snedeker SM, Lubahn DB, Schomberg DW, and Smith EP (1996). Estrogen receptor gene disruption: Molecular characterization and experimental and clinical phenotypes. Recent Prog. Horm. Res. 51: 159-188.
6.
Quarmby VE and Korach KS (1984). Differential regulation of protein synthesis by estradiol in uterine component tissues. Endocrinology115: 687-697.
7.
Quarmby VE and Korach KS (1984). The influence of 17 beta-estradiol on patterns of cell division in the uterus. Endocrinology114: 694-702.
8.
Raj SG, Thompson IE, and Berger MJ (1977). Clinical aspects of the polycystic ovary syndrome . Obstet. Gynecol. 49: 552-556.
9.
Rosenfeld MG , Nelson C., Crenshaw EB, III, Elsholtz HP, Lira SA, Mangalam HJ, Franco R., Waterman M., Weinberger C., Hollenberg SM, Giguere V., Ong E., and Evans RM (1987). Developmental and hormonal regulation of neuroendocrine gene transcription . Recent Prog. Horm. Res. 43: 499-534.